🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the effects of idelalisi...
Status
Terminated
Location
Sansum Clinic
Start Date
2015-04-21
Trial ID
NCT01980875
Treatments Being Tested
A Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosi...
Status
Completed
Location
Site Reference ID/Investigator #047
Start Date
2013-03
Trial ID
NCT01722487
Treatments Being Tested
The primary objective of the study is to evaluate the safety of idelalisib ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2010-03-25
Trial ID
NCT01088048
The primary objective of this study is to evaluate the efficacy of ibrutini...
Status
Completed
Location
Site Reference ID/Investigator# 0241
Start Date
2014-10-06
Trial ID
NCT02264574
Treatments Being Tested
This is an open-label study to evaluate tolerability, safety, efficacy and ...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04
Trial ID
NCT01563055
Treatments Being Tested
This study evaluates the combination of ublituximab, a novel monoclonal ant...
Status
Terminated
Location
TG Therapeutics Investigational Trial Site
Start Date
2015-11-19
Trial ID
NCT02612311
Treatments Being Tested
This is a Phase 2, multi-center, open label, randomized clinical study to e...
Status
Terminated
Location
Chef du Service d'Hematologie Clinique CHU Clemenceau
Start Date
2004-09
Trial ID
NCT00151736
Treatments Being Tested
This open-label, multicenter, randomized Phase III study is designed to com...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2014-12-31
Trial ID
NCT02242942
Treatments Being Tested
The purpose of this study was to evaluate the safety and efficacy of ofatum...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2008-12-22
Trial ID
NCT00748189
Treatments Being Tested
This study is an open-label, single arm, phase II study of chlorambucil in ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-04
Trial ID
NCT01808326
Treatments Being Tested